期刊文献+

不同左室心肌Ganau构型的高血压患者血清NT-proBNP浓度的变化 被引量:1

THE RESEARCH OF PLAMA N-TERMINAL PRO-B-TYPE NATRIURETIC PEPTIDE ON DIFFERENT LEFT VENTRICULAR GANAU PATTERNS IN HYPERTENSION PATIENTS
原文传递
导出
摘要 目的研究不同心肌Ganau构型的高血压患者血清NT-proBNP浓度的变化。方法选取2009年6月—2010年6月于心内科门诊及心内科病房就诊的高血压患者共184例,按照不同心肌构型分为四组,左室正常构型组(A组),左室向心性重构组(B组),左室向心性肥厚组(C组),以及左室离心性肥厚组(D组),并测定各组血清NT-proBNP的浓度进行统计学分析。结果各组间血清NT-proBNP的浓度存在明显差异,P值均<0.05。结论随着心肌构型严重性的改变,血清NT-proBNP浓度也逐渐明显升高。 Objective To study the levels of serum N-Terminal oro-B-type natriuretic peptide on different left ventricular Ganau patterns in hypertension patients.Methods From 2009.6 to 2010.6,184 patients diagnosed for essential hypertension were selected in department of intracardiac.All patients were divided to four groups based on different patterns,they were normal patterns group(group A),concentric reconstitution group(group B),concentric hypertrophy group(group C) and eccentric hypertrophy group(group D).The level was measured in all subjectsResults It was found that the concentration of serum NT-proBNP in four groups was different,P0.05.ConclusionThe concentration of serum NT-proBNP is positive correlation with change of ventricular pattern severity.
作者 尹杰 段海燕
出处 《中国煤炭工业医学杂志》 2011年第4期491-493,共3页 Chinese Journal of Coal Industry Medicine
关键词 左室心肌 高血压 Ganau构型 血清NT-pro-BNP left ventricular hypertension Ganau patterns serum NT-proBNP
  • 相关文献

参考文献13

  • 1陈广胜,李新立,许迪,吴成权,王震震,廖静.原发性高血压患者血清脑利钠肽水平与左室重构的关系[J].心脑血管病防治,2005,5(2):7-9. 被引量:6
  • 2赵松山,刘友梅,姚家邦,杨增仁,梁月琴,张是敬.中国成年女子体表面积的测量[J].营养学报,1987,10(3):200-207. 被引量:41
  • 3赵松山,刘友梅,姚家邦,高书旺,张是敬.中国成年男子体表面积的测量[J]营养学报,1984(02).
  • 4Kohno M,M inami M,Kano H,et al.Effect of angiotensin-converting enzyme inhibitor on left ventricular parameters and circulating brain natriuretic peptide in elderly hypertensives with left ventricular hypertrophy. Metabolism . 2000
  • 5Kitmman DW.Heart failure with normal systolic function. Clinics in Geriatric Medicine . 2000
  • 6Ganau A,Devereux RB,Roman MJ,et al.Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. Journal of the American College of Cardiology . 1992
  • 7Krumholz H M,Larson M,Levy D.Prognosis of left ventricular geometric patterns in the Framingham Heart Study. Journal of the American College of Cardiology . 1995
  • 8Devereux RB,Alonso DR,Lutas EM,et al.Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. The American Journal of Cardiology . 1986
  • 9Weber KT,Brilla CG,Janicki JS.Myocardial fibrosis: functional significance and regulatory factors. Cardiovascular Research . 1993
  • 10Hobbs FD,Davis RC,Roalfe AK,et al.Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: cohort study in representative and high risk community populations. British Medical Journal . 2002

二级参考文献15

  • 1Yasue H, Yoshimura M, Sumida H, et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure[J]. Circulation, 1994,90:195-203.
  • 2Kinnunen P, Vuolteenaho O, Ruskoaho H. Mechanisms of atrial and brain natriuretic peptide release from rat ventricular myocardium:effect of stretching[J]. Endocrinology,1993,132:1961-1970.
  • 3Sahn DJ, De Maria A, Kisslo J, et al. Recommendations regarding quantitation in M-mode echocardiography:results of a survey of echocardiographic measurements[J]. Circulation, 1978,58:1072-1083.
  • 4Devereux RB, Reichek N. Echocardiographic drtermination of left ventricular mass in man:anatomic validation of the method[J]. Circulation,1977,55:6313-618.
  • 5Nishikimi T, Yoshihara F, Morimoto ,A et al. Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension[J]. Hypertension,1996,28:22-30.
  • 6Koren MJ, Devereux RB, Casale PN, et al. Relation of left ventricular mass and geometry to morbidity and mortality in uncompl8icated essential hypertension[J]. Ann Intern Med, 1991,114:345-352.
  • 7Wachtell K, Dahlof B, Rokkedal J, et al. Change of left ventricular geometric pattern after 1 year of antihypertensive treatment:the Losartan Intervention For Endpoint reduction in hypertension(LIFE) study[J]. Am Heart J, 2002,144:1057-1064.
  • 8Sudoh T, Kangawa K, Minamino N, et al. A new natriuretic peptide in porcine brain[J]. Nature,1988,332:78-81.
  • 9Lemos JA, McGuire DK, Drazner MH.B-type natriuretic peptide in cardiovascular disease[J]. Lancet, 2003,362:316-322.
  • 10Kohno M, Horio T, Yokokawa K,et al. Brain natriuretic peptide as a cardiac hormone in essetial hypertension[J]. Am J Med,1992,92:29-34.

共引文献45

同被引文献17

  • 1Auer J, Berent 1R, Lassnig E, et al. C-reactive protein and coronary artery. Jpn Heart J, 2002,43 : 607-619.
  • 2Balion C, Santaguida PL, Hill S, et al. Testing for BNP and NT-proBNP in the diagnosis and prognosis of heart failure. Evid Rep Technol Assess(Full Rep) ,2006,12:147.
  • 3Iwanaga Y, Nishi I, Furuichi S, et al. B-type natriuretic pep- tide strongly reflects diastolic wall stress in patients with chronic heart failure: Comparison between systolic and diastolic heart failure. J Am Coil Cardiol,2006,47:742-748.
  • 4Hall C. Essential biochemistry and physiology of (NT-proBNP). Eur J Heart Fail, 2004,6 : 257-260.
  • 5Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines(Committee on the Management of Patients with Unstable Angina). J Am Coil Cardiol,2002,40: 1366-1374.
  • 6Panteghini M. Acute coronary syndrome.Biochemical strategies in the troponin era. Chest, 2002,122 : 1428-1435.
  • 7Grabowski M, Filipiak KJ, Malek LA. Admission B-type natri- uretic peptide assessment improves early risk stratification by Kil-lip classes and TIMI risk score in patients with acute ST eleva- tion myocardial infarction treated with primary angioplasty. Int Cardiol, 2007,115 : 386-390.
  • 8Latini R, Aaggioni AP, Masson S. What dose the future hold for BNP in cardiology. Heart, 2011,86 : 601.
  • 9Foote RS, Periman JD, Siegel AH, et al. Detection of exercise- induced ischern in by changes in B-type natriuretic peptides. J Am Coil Cardiol,2004,44: 1980-1987.
  • 10De-lemos JA, Morrow DA. Brain natriuretie peptide measure- ment in acute coronary syndrome: Ready for clinical application. Circulation, 2002,106 : 2868-2870.

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部